RGS - Ann -
Regenerative medicine company, Regeneus (ASX: RGS), announced today that Lonza, the world’s largest manufacturer of stem cells will manufacture Regeneus’ off-the-shelf cell therapy, CryoShot® Canine, for registration in the US.
- Forums
- ASX - Day Trading
- daytrading jan 22 pre-market
daytrading jan 22 pre-market, page-10
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)